Literature DB >> 7175914

Comparative pathogenicity of Actinomyces species in mice.

M J Behbehani, H V Jordan.   

Abstract

The comparative pathogenicity of different species of Actinomyces was studied in a susceptible weanling-mouse model. After the intraperitoneal injection of strains of Actinomyces israeli, A. naeslundi, A. viscosus and Arachnia propionica, numerous abscesses developed in the intestine, mesentery, liver, and at the site of injection. Lesions were not produced by A. odontolyticus. A. naeslundi and A. viscosus produced acute lesions that resolved after a few weeks. Abscesses produced by rough strains of A. israeli and Arach. propionica persisted and led to a slowly progressive chronic infection. Viable organisms were always recovered from the lesions. Spread of the lesions by extension into other areas, including the thoracic cavity, led to the death of the animal after approximately 1 year. This study demonstrated a clear difference in the pattern of infection produced by the different species of Actinomyces as well as Arach. propionica.

Entities:  

Mesh:

Year:  1982        PMID: 7175914     DOI: 10.1099/00222615-15-4-465

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  4 in total

1.  Enhancement of experimental actinomycosis in mice by Eikenella corrodens.

Authors:  H V Jordan; D M Kelly; J D Heeley
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

2.  Persistence of associated gram-negative bacteria in experimental actinomycotic lesions in mice.

Authors:  H V Jordan; D M Kelly
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

Review 3.  An update on the management of endodontic biofilms using root canal irrigants and medicaments.

Authors:  Zahed Mohammadi; Mohammad Karim Soltani; Sousan Shalavi
Journal:  Iran Endod J       Date:  2014-03-08

4.  Structural elucidation of Tsukamurella pulmonis neutral polysaccharide and its visualization in infected mouse tissues by specific monoclonal antibodies.

Authors:  Adnan Saeed; Mariola Paściak; Sabina Górska; Ireneusz Ceremuga; Elżbieta Gamian; Piotr Ziółkowski; Marek Drab; Andrzej Gamian
Journal:  Sci Rep       Date:  2018-08-01       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.